The c.68-7T>A variant, initially described in one patient with breast and ovarian cancer in Italy [23], has been widely detected in France (82 times, UMD-BRCA2 database [24]) sometimes with co-occurrence of two different deleterious BRCA2 mutations. Here, BRCA2 is linked to ovarian cancer.